Abstract

BackgroundPediatric non-adherence to antiretroviral therapy (ART), loss to follow-up, and HIV drug resistance (HIVDR) are challenges to achieving UNAIDS’ targets of 90% of those diagnosed HIV-positive receiving treatment, and 90% of those receiving treatment achieving viral suppression. In Kenya, the pediatric population represents 8% of total HIV infections and pediatric virological failure is estimated at 33%. The monitoring of early warning indicators (EWIs) for HIVDR can help to identify and correct gaps in ART program functioning to improve HIV care and treatment outcomes. However, EWIs have not been integrated into health systems. We assessed challenges to the use of EWIs and solutions to challenges identified by frontline health administrators.MethodsWe conducted key informant interviews with health administrators who were fully knowledgeable of the ART program at 23 pediatric ART sites in 18 counties across Kenya from May to June 2015. Thematic content analysis identified themes for three EWIs: on-time pill pick-up, retention in care, and virological suppression.ResultsNine themes—six at the facility level and three at the patient level—emerged as major challenges to EWI monitoring. At the facility level, themes centered on system issues (e.g., slow return of viral load results), staff shortages and inadequate adherence counseling skills, lack of effective patient tracking and linkage systems, and lack of support for health personnel. At the patient level, themes focused on stigma, non-disclosure of HIV status to children who are age eligible, and little engagement of guardians in the children’s care.Practical solutions identified included the use of lay health workers (e.g., peer educators, community health workers) to implement a variety of care and treatment tasks, whole facility approaches to adherence counseling, adolescent peer support groups, and working with children directly as soon as they are age eligible.DiscussionThe monitoring of EWIs has not been routine in health facilities in Kenya due to several challenges. However, facilities have implemented novel strategies to address some of these barriers. Future work is needed to assess whether scale-up of some of these approaches can aid in the effective use of EWIs and improving HIV care outcomes among the pediatric population.

Highlights

  • Pediatric non-adherence to antiretroviral therapy (ART), loss to follow-up, and Human immunodeficiency virus (HIV) drug resistance (HIVDR) are challenges to achieving Joint United Nations Programme on HIV/AIDS (UNAIDS)’ targets of 90% of those diagnosed HIV-positive receiving treatment, and 90% of those receiving treatment achieving viral suppression

  • 2.6 million children younger than 15 years of age are living with HIV, 90% of whom reside in sub-Saharan Africa, and only 32% are accessing antiretroviral therapy (ART) [2]

  • Key informant interviews (KII) were conducted with participants from five types of facilities: teaching/referral hospital (n = 2), provincial hospital (n = 8), district hospital (n = 6), sub-district hospitals (n = 3), and health center/dispensary (n = 4)

Read more

Summary

Introduction

Pediatric non-adherence to antiretroviral therapy (ART), loss to follow-up, and HIV drug resistance (HIVDR) are challenges to achieving UNAIDS’ targets of 90% of those diagnosed HIV-positive receiving treatment, and 90% of those receiving treatment achieving viral suppression. In Kenya, children aged 0 to 14 accounted for 8% of total HIV infections (n = 120, 000) in 2016, with 45% in need of ART [3]. With such rates, achieving the second and third “90s” among the pediatric population is in danger. The prevention of HIV drug resistance (HIVDR) is critical within the pediatric population

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call